Zobrazeno 1 - 10
of 878
pro vyhledávání: '"Hamao Umezawa"'
Autor:
Hamao Umezawa
Small Molecular Immunomodifiers of Microbial Origin: Fundamental and Clinical Studies of Bestatin focuses on the results of experimental and clinical studies suggesting that bestatin and small molecular weight immunity-enhancing agents can contribute
Autor:
Hamao Umezawa
Plasmids are involved in the biosynthesis of many microbial secondary metabolites, and compounds which have various chemical structures are produced by microorganisms. Therefore, it is possible to find microbial products which have no antimicrobial a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1e9b552656801d6025491115ea71a14
https://doi.org/10.1159/000401495
https://doi.org/10.1159/000401495
Autor:
Hamao Umezawa
An effective treatment schedule with bleomycin in combination with mitomycin and a new effective area in treatment with neocarzinostatin was introduced. Studies on more useful derivatives or analogues of bleomycin and anthracycline antitumor antibiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c35c3f17a0eb5779c3b1f313994432d
https://doi.org/10.1159/000401474
https://doi.org/10.1159/000401474
Publikováno v:
ChemInform. 23
3′-Deoxy-3′-fluorokanamycin A ( 14 ) has been prepared by condensation of 6-azido-2,4-di- O -benzyl-3,6-dideoxy-3-fluoro-α- d - glucopyranosyl bromide ( 8 ) and 6- O -(2- O -acetyl-4,6- O -cyclohexylidene-3-deoxy-3-tosylamino-α- d -glucopyranos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4e3d2ec2cef9e599f2ba4fe8e02c476
https://doi.org/10.1002/chin.199207258
https://doi.org/10.1002/chin.199207258
Autor:
Masayuki Sakakibara, Kuniaki Tatsuta, Hiroyuki Kawai, Shohachi Nakajima, Hamao Umezawa, Noboru Otake, Nobuyasu Komeshima
Publikováno v:
The Journal of Antibiotics. 45:374-379
4'-O-Acyl derivatives of doxorubicin, daunorubicin, 13-deoxocarminomycin, 13-deoxo-10-hydroxycarminomycin, 13-deoxo-11-deoxycarminomycin were synthesized through the formation and mild acid hydrolysis of 2-oxazoline intermediates. The antitumor activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993efa5ed37e44b6c179b26e0612eb58
https://doi.org/10.7164/antibiotics.45.374
https://doi.org/10.7164/antibiotics.45.374
Autor:
Kouwa Yamashita, Keiko Watanabe, Shigeru Mizuguchi, Teruya Nakamura, Rumiko Nakanuma, Hamao Umezawa, Yutaka Hashimoto
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 527:208-213
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1df6fa52cb6a6f021061ce633ea011ad
https://doi.org/10.1016/s0378-4347(00)82102-7
https://doi.org/10.1016/s0378-4347(00)82102-7
Autor:
Hamao Umezawa, Tomohisa Takita
Publikováno v:
Structure and Bonding ISBN: 354009816X
Bleomycin (BLM) is a group of glycopeptide antibiotics produced by Streptomyces verticillus. It is now clinically used for the treatment of squamous cell carcinoma, malignant lymphoma etc. BLM is isolated as blu-colored amorphous powder from the cult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97bfaab51d0b10cc648e2fa39ae2b3b0
https://doi.org/10.1007/bfb0025287
https://doi.org/10.1007/bfb0025287